Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zofenopril + hydrochlorothiazide versus irbesartan + hydrochlorothiazide in uncontrolled essential hypertension
2008-002439-33Phase 3Completed
- Sponsor
- Menarini Group
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in essential hypertension comparing Zofenopril + hydrochlorothiazide with Irbesartan + hydrochlorothiazide (2 arms). Primary endpoint: Change in office sitting diastolic blood pressure. Started Jul 2008; status: completed.
02
Drugs
zofenoprilhydrochlorothiazideirbesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2008-002439-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002439-33.